Structurally flexible triethanolamine-core poly(amidoamine) dendrimers as effective nanovectors to deliver RNAi-based therapeutics

Acunzo, 2012, Small heat shock proteins HSP27 (HspB1), alphaB-crystallin (HspB5) and HSP22 (HspB8) as regulators of cell death, Int J Biochem Cell Biol, 44, 1622, 10.1016/j.biocel.2012.04.002 Alabi, 2012, Attacking the genome: emerging siRNA nanocarriers from concept to clinic, Curr Opin Pharmacol, 12, 427, 10.1016/j.coph.2012.05.004 Amarzguioui, 2008, Principles of Dicer substrate (d-siRNA) design and function, Methods Mol Biol, 442, 3, 10.1007/978-1-59745-191-8_1 Amarzguioui, 2006, Rational design and in vitro and in vivo delivery of Dicer substrate siRNA, Nat Protoc, 1, 508, 10.1038/nprot.2006.72 Ambros, 2004, The functions of animal microRNAs, Nature, 431, 350, 10.1038/nature02871 Anderson, 2003, Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance, Oligonucleotides, 13, 303, 10.1089/154545703322616989 Bader, 2010, The promise of microRNA replacement therapy, Cancer Res, 70, 7027, 10.1158/0008-5472.CAN-10-2010 Bao, 2006, Glioma stem cells promote radioresistance by preferential activation of the DNA damage response, Nature, 444, 756, 10.1038/nature05236 Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 Behr, 1997, The proton sponge: a trick to enter cells the viruses did not exploit, Chimia, 51, 34, 10.2533/chimia.1997.34 Berkhout, 2009, Towards a durable RNAi gene therapy for HIV–AIDS, Expert Opin Biol Ther, 9, 161, 10.1517/14712590802653619 Bolcato-Bellemin, 2007, Sticky overhangs enhance siRNA-mediated gene silencing, Proc Natl Acad Sci U S A, 104, 16050, 10.1073/pnas.0707831104 Bouillon, 2010, Synthesis of poly(amino)ester dendrimers via active cyanomethyl ester intermediates, J Org Chem, 75, 8685, 10.1021/jo101739x Boussif, 1995, A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine, Proc Natl Acad Sci U S A, 92, 7297, 10.1073/pnas.92.16.7297 Brass, 2008, Identification of host proteins required for HIV infection through a functional genomic screen, Science, 319, 921, 10.1126/science.1152725 Brault, 2010, PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers, Haematologica, 95, 1004, 10.3324/haematol.2009.017079 Calin, 2006, MicroRNA signatures in human cancers, Nat Rev Cancer, 6, 857, 10.1038/nrc1997 Castanotto, 2009, The promises and pitfalls of RNA-interference-based therapeutics, Nature, 457, 426, 10.1038/nature07758 Christ, 2008, Transportin-SR2 imports HIV into the nucleus, Curr Biol, 18, 1192, 10.1016/j.cub.2008.07.079 Cornford, 2000, Heat shock protein expression independently predicts clinical outcome in prostate cancer, Cancer Res, 60, 7099 Couto, 2010, Viral vector-mediated RNA interference, Curr Opin Pharmacol, 10, 534, 10.1016/j.coph.2010.06.007 de Fougerolles, 2007, Interfering with disease: a progress report on siRNA-based therapeutics, Nat Rev Drug Discov, 6, 443, 10.1038/nrd2310 Esquela-Kerscher, 2006, Oncomirs — microRNAs with a role in cancer, Nat Rev Cancer, 6, 259, 10.1038/nrc1840 Fire, 1998, Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans, Nature, 391, 806, 10.1038/35888 Fusi, 2004, Treatment options in hormone-refractory metastatic prostate carcinoma, Tumori, 90, 535, 10.1177/030089160409000601 Gallagher, 2006, Hormone-refractory prostate cancer: a shifting paradigm in treatment, Clin J Oncol Nurs, 10, 233, 10.1188/06.CJON.233-240 Godlewski, 2010, MicroRNAs and glioblastoma; the stem cell connection, Cell Death Differ, 17, 221, 10.1038/cdd.2009.71 Guillot-Nieckowski, 2007, Dendritic vectors for gene transfection, New J Chem, 31, 1111, 10.1039/B614877H Haensler, 1993, Polyamidoamine cascade polymers mediate efficient transfection of cells in culture, Bioconjug Chem, 4, 372, 10.1021/bc00023a012 Hannon, 2002, RNA interference, Nature, 418, 244, 10.1038/418244a He, 2004, MicroRNAs: small RNAs with a big role in gene regulation, Nat Rev Genet, 5, 522, 10.1038/nrg1379 Huntzinger, 2011, Gene silencing by microRNAs: contributions of translational repression and mRNA decay, Nat Rev Genet, 12, 99, 10.1038/nrg2936 Jemal, 2010, Cancer statistics, 2010, CA Cancer J Clin, 60, 277, 10.3322/caac.20073 Kan, 2010, Diverse somatic mutation patterns and pathway alterations in human cancers, Nature, 466, 869, 10.1038/nature09208 Kanasty, 2012, Action and reaction: the biological response to siRNA and its delivery vehicles, Mol Ther, 20, 513, 10.1038/mt.2011.294 Kiessling, 2011, High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade, Blood, 117, 2433, 10.1182/blood-2010-09-305128 Kim, 2005, Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy, Nat Biotechnol, 23, 222, 10.1038/nbt1051 Lang, 2012, Genome-wide profiling identified a set of miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells, PLoS One, 7, e36248, 10.1371/journal.pone.0036248 Lee, 2004, Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways, Cell, 117, 69, 10.1016/S0092-8674(04)00261-2 Liu, 2009, PAMAM dendrimers mediate siRNA delivery to target Hsp27 and produce potent antiproliferative effects on prostate cancer cells, ChemMedChem, 4, 1302, 10.1002/cmdc.200900076 Liu, 2011, Structurally flexible triethanolamine core PAMAM dendrimers are effective nanovectors for DNA transfection in vitro and in vivo to the mouse thymus, Bioconjugate Chem, 22, 2461, 10.1021/bc200275g Liu, 2012, Efficient delivery of sticky siRNA and potent gene silencing in a prostate cancer model using a generation 5 triethanolamine-core PAMAM dendrimer, Mol Pharmaceutics, 9, 470, 10.1021/mp2006104 Liu, 2012, Dendrimers as non-viral vectors for siRNA delivery, New J Chem, 36, 256, 10.1039/C1NJ20408D Liu, 2013, Poly(amidoamine) dendrimes as non-viral vectors for the delivery of RNA therapeutics, 73 Louis, 2007, The 2007 WHO classification of tumours of the central nervous system, Acta Neuropathol, 114, 97, 10.1007/s00401-007-0243-4 Martinez, 2009, Progress in the therapeutic applications of siRNAs against HIV-1, Methods Mol Biol, 487, 343 Mignani, 2013, Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview, Adv Drug Deliv Rev, 10.1016/j.addr.2013.01.001 Nekhai, 2006, Transcriptional and post-transcriptional regulation of HIV-1 gene expression: role of cellular factors for Tat and Rev, Future Microbiol, 1, 417, 10.2217/17460913.1.4.417 Novina, 2002, siRNA-directed inhibition of HIV-1 infection, Nat Med, 8, 681, 10.1038/nm725 Pasquinelli, 2012, MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship, Nat Rev Genet, 13, 271, 10.1038/nrg3162 Pham, 2004, A Dicer-2-dependent 80s complex cleaves targeted mRNAs during RNAi in Drosophila, Cell, 117, 83, 10.1016/S0092-8674(04)00258-2 Posocco, 2013, Impact of siRNA overhangs for dendrimer-mediated siRNA delivery and gene silencing, Mol Pharm, 10, 3262, 10.1021/mp400329g Quéléver, 2013, Poly(aminoester) dendrimers: design, synthesis and characterization, 167 Ravina, 2010, Knocking down gene expression with dendritic vectors, Mini Rev Med Chem, 10, 73, 10.2174/138955710791112569 Reebye, 2013, A novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo, Hepatology Rocchi, 2004, Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer, Cancer Res, 64, 6595, 10.1158/0008-5472.CAN-03-3998 Rocchi, 2005, Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis, Cancer Res, 65, 11083, 10.1158/0008-5472.CAN-05-1840 Rocchi, 2006, Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitro, BJU Int, 98, 1082, 10.1111/j.1464-410X.2006.06425.x Rose, 2005, Functional polarity is introduced by Dicer processing of short substrate RNAs, Nucleic Acids Res, 33, 4140, 10.1093/nar/gki732 Rossi, 2006, RNAi as a treatment for HIV-1 infection, Biotechniques, 25, 10.2144/000112167 Rossi, 2007, Genetic therapies against HIV, Nat Biotechnol, 25, 1444, 10.1038/nbt1367 Scherer, 2007, Progress and prospects: RNA-based therapies for treatment of HIV infection, Gene Ther, 14, 1057, 10.1038/sj.gt.3302977 Schroeder, 2010, Lipid-based nanotherapeutics for siRNA delivery, J Intern Med, 267, 9, 10.1111/j.1365-2796.2009.02189.x Shen, 2007, Importance of size-to-charge ratio in construction of stable and uniform nanoscale RNA/dendrimer complexes, Org Biomol Chem, 5, 3674, 10.1039/b711242d Shen, 2012, Nanovector delivery of siRNA for cancer therapy, Cancer Gene Ther, 19, 367, 10.1038/cgt.2012.22 Silber, 2008, miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells, BMC Med, 6, 14, 10.1186/1741-7015-6-14 Singh, 2004, Identification of human brain tumour initiating cells, Nature, 432, 396, 10.1038/nature03128 Soifer, 2007, MicroRNAs in disease and potential therapeutic applications, Mol Ther, 15, 2070, 10.1038/sj.mt.6300311 Soutschek, 2004, Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs, Nature, 432, 173, 10.1038/nature03121 Stavridi, 2010, Targeted therapeutic approaches for hormone-refractory prostate cancer, Cancer Treat Rev, 36, 122, 10.1016/j.ctrv.2009.06.001 Tan, 2011, Engineering nanocarriers for siRNA delivery, Small, 7, 841, 10.1002/smll.201001389 Tang, 1996, In vitro gene delivery by degraded polyamidoamine dendrimers, Bioconjug Chem, 7, 703, 10.1021/bc9600630 Tannock, 2004, Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer, N Engl J Med, 351, 1502, 10.1056/NEJMoa040720 Tomalia, 1985, A new class of polymers: starburst-dendritic macromolecules, Polym J, 17, 117, 10.1295/polymj.17.117 Tomalia, 1990, Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter, Angew Chem Int Ed Engl, 29, 138, 10.1002/anie.199001381 Tomari, 2004, A protein sensor for siRNA asymmetry, Science, 306, 1377, 10.1126/science.1102755 Tseng, 2009, Lipid-based systemic delivery of siRNA, Adv Drug Deliv Rev, 61, 721, 10.1016/j.addr.2009.03.003 Vögtle, 2009 Wagner, 2012, Polymers for siRNA delivery: inspired by viruses to be targeted, dynamic, and precise, Acc Chem Res, 45, 1005, 10.1021/ar2002232 Wang, 2012, The seemingly trivial yet challenging synthesis of poly(aminoester) dendrimers, Curr Med Chem, 19, 5011, 10.2174/0929867311209025011 Whitehead, 2009, Knocking down barriers: advances in siRNA delivery, Nat Rev Drug Discov, 8, 129, 10.1038/nrd2742 Wu, 2005, Polycationic dendrimers interact with RNA molecules: polyamine dendrimers inhibit the catalytic activity of Candida ribozymes, Chem Commun, 313, 10.1039/b414241a Wu, 2010, Accelerated hepatocellular carcinoma development in mice expressing the Pim-3 transgene selectively in the liver, Oncogene, 29, 2228, 10.1038/onc.2009.504 Zhou, 2006, PAMAM dendrimers for efficient siRNA delivery and potent gene silencing, Chem Commun, 2362, 10.1039/b601381c Zhou, 2009, Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells, Nucleic Acids Res, 37, 3094, 10.1093/nar/gkp185 Zhou, 2011, Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice, Mol Ther, 19, 2228, 10.1038/mt.2011.207 Zoubeidi, 2012, Small heat shock proteins in cancer therapy and prognosis, Int J Biochem Cell Biol, 44, 1646, 10.1016/j.biocel.2012.04.010